CervoMed Inc. (CRVO) — Financial statements
Income statement, balance sheet, and cash flow for CervoMed Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 4 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | ||||||
| R&D Expenses | 22↑16.1% | 19↑122.8% | 8↑531.4% | 1↓84.3% | 8 | |
| General & Administrative Expenses | 10↑14.4% | 9↑40.6% | 7↑204.8% | 2↓71.3% | 7 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 10↑14.4% | 9↑40.6% | 7↑204.8% | 2↓71.3% | 7 | |
| Other Expenses | 0.00↑100.0% | -10↓36.3% | -7 | 0.00↓100.0% | 9 | |
| Operating Expenses | 32↑77.2% | 18↑133.3% | 8↑124.8% | 3↓85.9% | 25 | |
| Total Costs & Expenses | 32↑77.2% | 18↑133.3% | 8↑124.8% | 3↓85.9% | 25 | |
| Operating Results | ||||||
| Operating Income | -28↓55.2% | -18↓133.3% | -8↓124.8% | -3↑85.9% | -25 | |
| Depreciation & Amortization | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 0.09 | |
| EBITDA | -28↓55.2% | -18↓133.3% | -8↓34.6% | -6↑63.6% | -16 | |
| EBIT | -28↓55.2% | -18↓133.3% | -8↓34.6% | -6↑63.8% | -16 | |
| Interest & Other Income | ||||||
| Net Interest Income | 1↓31.0% | 2↑782.9% | 0.22↑256.0% | 0.06↓55.2% | 0.14 | |
| Interest Income | 1↓31.0% | 2↑782.7% | 0.22↑252.6% | 0.06↓54.7% | 0.14 | |
| Interest Expense | 0.00 | 0.00 | 0.00↓100.0% | 0.00 | 0.00 | |
| Non-Operating Income | 0.00 | 0.00 | 0.00↓100.0% | 2↑126.9% | -9 | |
| Other Income / Expenses | 1↓31.4% | 2↓65.7% | 6↑342.4% | -2↓1792.9% | 0.14 | |
| Income Before Tax | -27↓65.5% | -16↓650.1% | -2↑62.6% | -6↑76.4% | -25 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00↑100.0% | -0.44 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -27↓65.5% | -16↓650.1% | -2↑62.6% | -6↑75.9% | -24 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -27↓65.5% | -16↓650.1% | -2↑62.6% | -6↑75.9% | -24 | |
| Bottom-Line Net Income | -27↓65.5% | -16↓650.1% | -2↑62.6% | -6↑75.9% | -24 | |
| EPS (Basic) | -2.98↓47.5% | -2.02↓146.3% | -0.82↑92.7% | -11.20↑39.5% | -18.51 | |
| EPS (Diluted) | -2.98↓47.5% | -2.02↓146.3% | -0.82↑92.7% | -11.20↑39.5% | -18.51 | |
| Weighted Average Shares | 9↑12.0% | 8↑203.4% | 3↑413.6% | 0.52↓60.2% | 1 | |
| Weighted Average Diluted Shares | 9↑12.0% | 8↑203.4% | 3↑413.6% | 0.52↓60.2% | 1 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.